{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T09:38:48Z","timestamp":1794476328034,"version":"4.9.1"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1097\/hjh.0b013e3283551e98","type":"journal-article","created":{"date-parts":[[2012,6,22]],"date-time":"2012-06-22T16:56:04Z","timestamp":1340384164000},"page":"1656-1664","source":"Crossref","is-referenced-by-count":111,"title":["Sequential nephron blockade versus sequential renin\u2013angiotensin system blockade in resistant hypertension"],"prefix":"10.1097","volume":"30","author":[{"given":"Guillaume","family":"Bobrie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Frank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Azizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9verine","family":"Peyrard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Boutouyrie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Chatellier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Laurent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00ebl","family":"Menard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Fran\u00e7ois","family":"Plouin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-23-20210208","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1161\/01.HYP.0000107251.49515.c2","article-title":"Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.","volume":"42","author":"Chobanian","year":"2003","journal-title":"Hypertension"},{"key":"R2-23-20210208","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1097\/HJH.0b013e3282f0580f","article-title":"2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension.","volume":"25","author":"Mancia","year":"2007","journal-title":"J Hypertens"},{"key":"R3-23-20210208","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1097\/00004872-200111000-00018","article-title":"High prevalence of cardiac and extracardiac target organ damage in refractory hypertension.","volume":"19","author":"Cuspidi","year":"2001","journal-title":"J Hypertens"},{"key":"R4-23-20210208","doi-asserted-by":"crossref","first-page":"438","DOI":"10.7326\/0003-4819-136-6-200203190-00007","article-title":"INDANA Project Steering CommitteeINdividual Data ANalysis of Antihypertensive intervention. J-shaped relationship between blood pressure and mortality in hypertensive patients: new insights from a meta-analysis of individual-patient data.","volume":"136","author":"Boutitie","year":"2002","journal-title":"Ann Intern Med"},{"key":"R5-23-20210208","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1161\/HYPERTENSIONAHA.108.189141","article-title":"Resistant hypertension: diagnosis, evaluation, and treatment. Scientific Statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research.","volume":"51","author":"Calhoun","year":"2008","journal-title":"Hypertension"},{"key":"R6-23-20210208","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1056\/NEJMcp041698","article-title":"Clinical practice. Resistant or difficult-to-control hypertension.","volume":"355","author":"Moser","year":"2006","journal-title":"N Engl J Med"},{"key":"R7-23-20210208","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/j.jacc.2008.08.036","article-title":"Resistant hypertension: an overview of evaluation and treatment.","volume":"52","author":"Sarafidis","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"R8-23-20210208","first-page":"48","article-title":"Role of the renin-angiotensin system in control of sodium excretion and arterial pressure.","volume":"591","author":"Hall","year":"1990","journal-title":"Acta Physiol Scand"},{"key":"R9-23-20210208","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/0002-9343(75)90527-6","article-title":"The renin axis and vasoconstriction volume analysis for understanding and treating renovascular and renal hypertension.","volume":"58","author":"Laragh","year":"1975","journal-title":"Am J Med"},{"key":"R10-23-20210208","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0895-7061(99)00005-9","article-title":"Beta-adrenergic receptor blockade as a therapeutic approach for suppressing the renin-angiotensin-aldosterone system in normotensive and hypertensive subjects.","volume":"12","author":"Blumenfeld","year":"1999","journal-title":"Am J Hypertens"},{"key":"R11-23-20210208","doi-asserted-by":"crossref","first-page":"F133","DOI":"10.1152\/ajprenal.00227.2002","article-title":"Upregulation of Na transporter abundances in response to chronic thiazide or loop diuretic treatment in rats.","volume":"284","author":"Na","year":"2003","journal-title":"Am J Physiol Renal Physiol"},{"key":"R12-23-20210208","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1161\/01.CIR.0000131449.94713.AD","article-title":"Combined blockade of the renin-angiotensin system with angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists.","volume":"109","author":"Azizi","year":"2004","journal-title":"Circulation"},{"key":"R13-23-20210208","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1097\/00005344-199703000-00010","article-title":"Sequential nephron blockade breaks resistance to diuretics in edematous states.","volume":"29","author":"Knauf","year":"1997","journal-title":"J Cardiovasc Pharmacol"},{"key":"R14-23-20210208","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1097\/HJH.0b013e3282f76792","article-title":"Teletransmission of home blood pressure monitoring: making it easier.","volume":"26","author":"Bobrie","year":"2008","journal-title":"J Hypertens"},{"key":"R15-23-20210208","first-page":"319","article-title":"Clinical use of ambulatory blood pressure monitoring. Participants of the 1999 Consensus Conference on Ambulatory Blood Pressure Monitoring.","volume":"4","author":"Staessen","year":"1999","journal-title":"Blood Press Monit"},{"key":"R16-23-20210208","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1056\/NEJMra0907219","article-title":"Use of diuretics in patients with hypertension.","volume":"361","author":"Ernst","year":"2009","journal-title":"N Engl J Med"},{"key":"R17-23-20210208","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1097\/HJH.0b013e32832810ed","article-title":"Aldosterone-receptor antagonism in hypertension.","volume":"27","author":"Jansen","year":"2009","journal-title":"J Hypertens"},{"key":"R18-23-20210208","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1161\/HYPERTENSIONAHA.109.140988","article-title":"Efficacy of spironolactone therapy in patients with true resistant hypertension.","volume":"55","author":"De Souza","year":"2010","journal-title":"Hypertension"},{"key":"R19-23-20210208","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1097\/HJH.0b013e32833d4c99","article-title":"Management of resistant arterial hypertension: role of spironolactone versus double blockade of the renin-angiotensin-aldosterone system.","volume":"28","author":"Alvarez-Alvarez","year":"2010","journal-title":"J Hypertens"},{"key":"R20-23-20210208","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1097\/HJH.0b013e3280d9434e","article-title":"Aldosterone antagonist therapy in resistant hypertension.","volume":"25","author":"Zannad","year":"2007","journal-title":"J Hypertens"},{"key":"R21-23-20210208","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1161\/HYPERTENSIONAHA.111.169961","article-title":"Addition of spironolactone in patients with resistant arterial hypertension (ASPIRANT): a randomized, double-blind, placebo-controlled trial.","volume":"57","author":"Vaclavik","year":"2011","journal-title":"Hypertension"},{"key":"R22-23-20210208","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/0002-9149(87)91030-7","article-title":"Efficacy and tolerance of spironolactone in essential hypertension.","volume":"60","author":"Jeunemaitre","year":"1987","journal-title":"Am J Cardiol"},{"key":"R23-23-20210208","doi-asserted-by":"crossref","first-page":"F252","DOI":"10.1152\/ajprenal.2000.279.2.F252","article-title":"Differential subcellular localization of ENaC subunits in mouse kidney in response to high- and low-Na diets.","volume":"279","author":"Loffing","year":"2000","journal-title":"Am J Physiol Renal Physiol"},{"key":"R24-23-20210208","doi-asserted-by":"crossref","first-page":"F923","DOI":"10.1152\/ajprenal.00015.2002","article-title":"Sodium transporter abundance profiling in kidney: effect of spironolactone.","volume":"283","author":"Nielsen","year":"2002","journal-title":"Am J Physiol Renal Physiol"},{"key":"R25-23-20210208","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1001\/jama.289.19.2534","article-title":"Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis.","volume":"289","author":"Psaty","year":"2003","journal-title":"JAMA"},{"issue":"Suppl 2","key":"R26-23-20210208","doi-asserted-by":"crossref","first-page":"S185","DOI":"10.1111\/j.1365-2125.1979.tb04689.x","article-title":"Diuretics as initial treatment for essential hypertension.","volume":"7","author":"Finnerty","year":"1979","journal-title":"Br J Clin Pharmacol"},{"key":"R27-23-20210208","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1161\/01.HYP.0000179582.42830.1d","article-title":"Improvement in blood pressure with inhibition of the epithelial sodium channel in blacks with hypertension.","volume":"46","author":"Saha","year":"2005","journal-title":"Hypertension"},{"key":"R29-23-20210208","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1161\/01.HYP.0000161880.59963.da","article-title":"Systematic review of combined angiotensin-converting enzyme inhibition and angiotensin receptor blockade in hypertension.","volume":"45","author":"Doulton","year":"2005","journal-title":"Hypertension"},{"key":"R30-23-20210208","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1097\/00004872-200310000-00016","article-title":"Dual renin-angiotensin system blockade restores blood pressure-renin dependency in individuals with low renin concentrations.","volume":"21","author":"Azizi","year":"2003","journal-title":"J Hypertens"},{"key":"R31-23-20210208","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJMoa0801317","article-title":"Telmisartan, ramipril, or both in patients at high risk for vascular events.","volume":"358","author":"ONTARGET Investigators, Yusuf","year":"2008","journal-title":"N Engl J Med"},{"key":"R32-23-20210208","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0002-8703(83)90199-0","article-title":"Double-blind comparison between propranolol and bendroflumethiazide in captopril-treated resistant hypertensive patients.","volume":"106","author":"Staessen","year":"1983","journal-title":"Am Heart J"},{"key":"R34-23-20210208","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1001\/jama.2010.1205","article-title":"Minimizing bias due to confounding by indication in comparative effectiveness research: the importance of restriction.","volume":"304","author":"Psaty","year":"2010","journal-title":"JAMA"}],"container-title":["Journal of Hypertension"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00004872-201208000-00023","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,14]],"date-time":"2021-04-14T02:09:10Z","timestamp":1618366150000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00004872-201208000-00023"}},"subtitle":["a prospective, randomized, open blinded endpoint study"],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":32,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/hjh.0b013e3283551e98","relation":{},"ISSN":["0263-6352"],"issn-type":[{"value":"0263-6352","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]}}}